Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

MS symptoms delayed by new drug

  • Comment

Multiple sclerosis (MS) symptoms may be delayed by a new drug if given to the patients when they are in the early stages of the illness.

The research shows that, in tests, the drug glatiramer acetate delayed the onset of chronic MS and reduced the chance of patients getting a confirmed, long-term diagnosis of MS by almost half in three years. It also reduced the frequency of symptoms in patients with intermittent, or ‘relapsing-remitting’ MS, by 30%.

THe study stressed that the the drug is not a cure, but can only delay the onset of the illness.

For many patients, an initial burst of symptoms quickly fade away, in what is known as ‘clinically isolated syndrome’(CIS). CIS does not always lead to long-term MS, which only becomes confirmed if symptoms return.

At present, glatiramer acetate has only been recommended by NICE for confirmed MS sufferers.

The drug, which costs £6,650 to treat one patient for a year, was only approved for use by the NHS after its manufacturer agreed to pay some of the costs if it proved ineffective.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs